go back

Dronabinol, Oral

Vermont rates for HCPCS Q0167

Dronabinol, 2.5 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $2 · 10th–90th $1$20%50%10th90th$2Professionalmedian $2 · 10th–90th $2$20%50%$2$1.0$2.0$5.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1.66
Median
$1.66
Typical High
$1.66
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1.41
Median
$1.51
Typical High
$1.86
Cigna
Setting
Professional
Modifier
Global
Typical Low
$1.51
Median
$1.66
Typical High
$1.66
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$3.09
Median
$3.09
Typical High
$3.09
United
Setting
Facility
Modifier
Global
Typical Low
$1.51
Median
$1.51
Typical High
$1.51
United
Setting
Professional
Modifier
Global
Typical Low
$1.35
Median
$1.45
Typical High
$2.45